ZCG-Backed Unimed Acquires Lagaay Medical Group
NEW YORK--(BUSINESS WIRE)--Universal Marine Medical Supply International (“Unimed” or the “Company”), the leading global provider of health and compliance solutions to the maritime industry, today announced its acquisition of Lagaay Medical Group (“Lagaay”), a global distributor of pharmaceutical products and medical devices, from B&S Group S.A. (“B&S”). Unimed is backed by affiliates of ZCG Private Equity, the private equity arm of ZCG, a privately held global firm.
Headquartered in the Netherlands, Lagaay has more than 140 years of experience providing high-quality medical supplies and pharmaceuticals for the marine industry. The company currently offers 10,000 medical SKUs across 100 active countries. This strategic acquisition expands Unimed’s presence in Rotterdam – the largest port in Europe – further enhancing Unimed’s ability to serve global clients with comprehensive healthcare and compliance solutions as part of its long-term growth strategy.
“This transaction marks a significant step in strengthening Unimed’s leadership in the maritime medical industry while deepening our partnerships with clients worldwide,” said Søren Andersen, Chief Executive Officer of Unimed. “We have long respected Lagaay’s business and global reach, particularly its strong presence in Rotterdam. We look forward to welcoming their team to Unimed, expanding our technology-driven subscription model to more clients, and continuing to execute on our growth strategy.”
“Joining forces with Unimed is the right next step for Lagaay, we have always perceived Unimed as a logical partner to capture synergies and strengthen the market position of Lagaay in the maritime medical industry,” said Peter van Mierlo, Chief Executive Officer of B&S. “We are proud of all that we have achieved with Lagaay’s management over the past 4,5 years, growing its client base and solutions, and focusing on operational excellence. We wish the team continued success in this next chapter.”
“We are pleased to announce this strategic transaction as Unimed continues to capitalize on both organic and inorganic growth opportunities,” said James Zenni, Founder, President and Chief Executive Officer of ZCG. “With this expansion, Unimed is even more well positioned to lead the maritime industry by delivering the platform of choice to clients globally. We look forward to supporting the combined Unimed and Lagaay leadership and the experienced teams as they integrate two companies.”
The transaction is expected to close in the coming days, subject to the satisfaction of customary closing conditions.
In connection with the acquisition, Unimed will launch a new branding and product suite at the Seatrade Cruise Global conference later this month, marking a new chapter in its evolution as a premier healthcare provider for the maritime sector. Attendees will get a first look at the refreshed identity, reflecting Unimed’s commitment to innovation and excellence
